AlliedPath, Inc. is a cancer-focused molecular diagnostics testing laboratory which offers an extensive menu of high-quality, solid tumor specific tests. We partner with regional hospital and reference laboratories to provide test results which are combined with expert pathology analysis into an easy to interpret patient report for the oncologist. The Company specializes exclusively in solid tumor testing, which is based on the genetic analysis of a patient’s tumor DNA, RNA, and proteins. The results provide relevant information for the physician to determine optimal treatment strategies, improving personalized medical care and enhancing quality of life for the patient.

AltheaDx is Bringing Theranostics into Clinical Use. Our proprietary gene expression profiles include assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer. We have a track record of reducing the time, risk, and cost of drug development by providing biomarker discovery and development to biopharma clients and clinical testing services to physicians. AltheaDx is located in a 20,000 sq. ft. building and operates laboratory service operations for biopharma customers in compliance with GLP requirements. CLIA certification is in process. The company has several key patents and technology affiliations with a variety of industry and academic institutions, including: NIH, NCI, UCSD, Sidney Kimmel Cancer Center, MD Anderso